Nu Skin Enterprises Inc. Common Stock (NUS)
Stock · NYSE · Health Care
$5.14as of 10/16/2026
Price chart
Active signals
NUS Signal Track Record
How signals performed across all stocks →What NUS's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 34 | -6.0% | 38% | September 18, 2026 |
| Bollinger Band Breakdown | 23 | -4.8% | 35% | September 16, 2026 |
| Bollinger Band Breakout | 18 | -2.3% | 39% | August 7, 2026 |
| 200-Day Moving Average TouchActive now | 12 | -2.3% | 25% | May 14, 2025 |
| Any 20-session window (baseline) | -4.2% | 37% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About NUS
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty…
- Sector
- Health Care
- Industry
- Other Pharmaceuticals
- Employees
- 2,800
- Website
- www.nuskin.com/
Fundamentals
- 1-day range
- $5.16$5.34
- Market cap
- $251.98M
- P/E (trailing)
- 4.30
- P/E (forward)
- 4.49
- EPS (trailing)
- $-4.48
- Dividend yield
- 9.03%
- Beta
- 0.96
- Avg. volume
- 538.4K
- Ex-dividend date
- August 28, 2026
- Dividend pay date
- September 9, 2026
How Nu Skin Enterprises Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 13, 2026 · via SEC EDGAR / Finnhub
Forecasts
1 analyst ratings
Nu Skin Enterprises Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- NUSNu Skin Enterprises Inc. Common Stock$5.14▼ 1.34%Market cap $251.98MP/E 4.30$4.45$11.67
- ZSTKZeroStack Corp. Common Stock$4▼ 5.21%Market cap $30.78MP/E —$1.32$20.45
- HKPDCellyan Biotechnology Co. Ltd Class A Ordinary Shares$0.11▲ 0.00%Market cap $16.93MP/E —$0.095$1.72
- COSMCosmos Health Inc. Common Stock$0.331▼ 1.49%Market cap $13.72MP/E —$0.1616$1.26
- MEDSDataMeds AI Inc. Common Stock$2.63▼ 7.72%Market cap $7.52MP/E —$0.8225$12.31
- HLFHerbalife Ltd. Common Shares$14.6▲ 0.21%Market cap $1.19BP/E 9.24$7.56$20.4
- CAHCardinal Health Inc. Common Stock$254.06▲ 0.14%Market cap $55.66BP/E 33.97$152.46$258.3
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| NUS Nu Skin Enterprises Inc. Common Stock | $251.98M | 4.30 | $5.14 | ▼ 1.34% | $4.45$11.67 |
| ZSTK ZeroStack Corp. Common Stock | $30.78M | — | $4 | ▼ 5.21% | $1.32$20.45 |
| HKPD Cellyan Biotechnology Co. Ltd Class A Ordinary Shares | $16.93M | — | $0.11 | ▲ 0.00% | $0.095$1.72 |
| COSM Cosmos Health Inc. Common Stock | $13.72M | — | $0.331 | ▼ 1.49% | $0.1616$1.26 |
| MEDS DataMeds AI Inc. Common Stock | $7.52M | — | $2.63 | ▼ 7.72% | $0.8225$12.31 |
| HLF Herbalife Ltd. Common Shares | $1.19B | 9.24 | $14.6 | ▲ 0.21% | $7.56$20.4 |
| CAH Cardinal Health Inc. Common Stock | $55.66B | 33.97 | $254.06 | ▲ 0.14% | $152.46$258.3 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Nu Skin: The Turnaround Is Behind Before It's StartedSeekingAlpha · 9/29/2026
Insider Activity
Insider Actions →- Edwina D. Woodbury · September 9, 2026 · Grant22 @ $4.85
- Edwina D. Woodbury · June 10, 2026 · Grant19 @ $5.43
- James M. Winett · June 2, 2026 · Sale7.2K @ $5.62
- Emma S. Battle · June 1, 2026 · Grant26.6K
- James M. Winett · June 1, 2026 · Grant26.6K
- Laura Nathanson · June 1, 2026 · Grant26.6K
- Mark A. Zorko · June 1, 2026 · Grant26.6K
- Edwina D. Woodbury · June 1, 2026 · Sale7.2K @ $5.7
- Edwina D. Woodbury · June 1, 2026 · Grant26.6K
- Pisano R. Thomas · June 1, 2026 · Grant26.6K
- Daniel W. Campbell · June 1, 2026 · Grant26.6K
- Laura Nathanson · May 11, 2026 · Sale2.7K @ $6.73
Institutional Ownership
March 31, 2026
- Total shares held
- 33.76M
- Total value held
- $232.15M
- Institutional holders
- 171
- Unknown4.29M
- Unknown2.14M
- Unknown2.06M
- Unknown2.02M
- Unknown1.79M
- Unknown1.76M
- Unknown1.74M
- Unknown1.70M
- Unknown1.24M
- Unknown1.19M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Nu Skin: Turnaround Narrative Gains Attention
A recent analysis suggests that Nu Skin's potential turnaround may be in its early stages. The company currently trades at a low price with a high dividend yield, while the stock is testing a key support level. This context highlights the contrast between current market sentiment and the long-term outlook discussed in the news.
Nu Skin: Turnaround Narrative Gains Attention. A recent analysis suggests that Nu Skin's potential turnaround may be in its early stages. The company currently trades at a low price with a high dividend yield, while the stock is testing a key support level. This context highlights the contrast between current market sentiment and the long-term outlook discussed in the news.